Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5366)
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
936
Price
$32.78
Total Value
$30.69K
Shares Held After
34,018
% of Holdings
2.7%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
6,064
Price
$32.30
Total Value
$195.87K
Shares Held After
34,954
% of Holdings
14.8%
UNITED THERAPEUTICS Corp (UTHR)
MALCOLM JAN — Director
Shares
50
Price
$474.68
Total Value
$23.73K
Shares Held After
220
% of Holdings
18.5%
Zoetis Inc. (ZTS)
PECK KRISTIN C — Director
Shares
10,800
Price
$127.55
Total Value
$1.38M
Shares Held After
101,337
% of Holdings
9.6%
Zoetis Inc. (ZTS)
PECK KRISTIN C — Director
Shares
9,200
Price
$126.46
Total Value
$1.16M
Shares Held After
112,137
% of Holdings
7.6%
Neogen Corporation (NEOG)
Nassif Mikheal — Director
Shares
23
Price
$10.94
Total Value
$251.62
Shares Held After
704
% of Holdings
3.3%
IRIDEX CORP (IRIX)
Dizon Romeo R — Chief Financial Officer
Shares
1,200
Price
$1.31
Total Value
$1.57K
Shares Held After
119,890
% of Holdings
1.0%
IRIDEX CORP (IRIX)
Dizon Romeo R — Chief Financial Officer
Shares
1,000
Price
$1.37
Total Value
$1.37K
Shares Held After
118,690
% of Holdings
0.8%
Seres Therapeutics, Inc. (MCRB)
Henn Matthew R — Chief Scientific Officer and EVP
Shares
89
Price
$8.47
Total Value
$753.83
Shares Held After
7,677
% of Holdings
1.1%
Seres Therapeutics, Inc. (MCRB)
DesRosier Thomas — Chief Legal Officer, EVP, Co-Chief Executive Officer, and Co-President
Shares
78
Price
$8.47
Total Value
$660.66
Shares Held After
7,789
% of Holdings
1.0%
Seres Therapeutics, Inc. (MCRB)
Young Teresa L. — EVP, Chief Commercial & Strategy Officer
Shares
75
Price
$8.47
Total Value
$635.25
Shares Held After
8,557
% of Holdings
0.9%
Seres Therapeutics, Inc. (MCRB)
Shaff Eric D. — Director
Shares
259
Price
$8.47
Total Value
$2.19K
Shares Held After
11,577
% of Holdings
2.2%
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Francis Richard D — President and CEO
Shares
286,122
Price
$34.22
Total Value
$9.79M
Shares Held After
605,771
% of Holdings
32.1%
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Francis Richard D — President and CEO
Shares
161,656
Price
$34.22
Total Value
$5.53M
Shares Held After
271,783
% of Holdings
37.3%
Vivani Medical, Inc. (VANI)
Williams Gregg — Director
Shares
264,551
Price
$1.26
Total Value
$333.33K
Shares Held After
29,781,952
% of Holdings
0.9%
Vivani Medical, Inc. (VANI)
Williams Gregg — Director
Shares
1,601,941
Price
$1.03
Total Value
$1.65M
Shares Held After
29,517,401
% of Holdings
5.4%
JOHNSON & JOHNSON (JNJ)
Swanson James D. — EVP, CIO
Shares
22,191
Price
$243.71
Total Value
$5.41M
Shares Held After
25,020
% of Holdings
47.0%
JOHNSON & JOHNSON (JNJ)
Swanson James D. — EVP, CIO
Shares
19,368
Price
$243.76
Total Value
$4.72M
Shares Held After
25,020
% of Holdings
43.6%
EXELIXIS, INC. (EXEL)
Oliver Bob — Director
Shares
21,162
Price
$43.90
Total Value
$929.01K
Shares Held After
21,120
% of Holdings
50.0%
EXELIXIS, INC. (EXEL)
Oliver Bob — Director
Shares
9,088
Price
$43.61
Total Value
$396.33K
Shares Held After
42,282
% of Holdings
17.7%
EXELIXIS, INC. (EXEL)
Eckhardt Sue Gail — Director
Shares
3,856
Price
$43.79
Total Value
$168.85K
Shares Held After
17,524
% of Holdings
18.0%
EXELIXIS, INC. (EXEL)
Senner Christopher J. — EVP and CFO
Shares
34,278
Price
$43.00
Total Value
$1.47M
Shares Held After
1,042,579
% of Holdings
3.2%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
7,040
Price
$51.96
Total Value
$365.82K
Shares Held After
43,720
% of Holdings
13.9%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
12,116
Price
$18.21
Total Value
$220.63K
Shares Held After
339,254
% of Holdings
3.4%
ARVINAS, INC. (ARVN)
Loomis David K — Chief Accounting Officer
Shares
1,016
Price
$11.89
Total Value
$12.08K
Shares Held After
30,800
% of Holdings
3.2%
ARVINAS, INC. (ARVN)
Berkowitz Noah — Chief Medical Officer
Shares
5,685
Price
$11.89
Total Value
$67.59K
Shares Held After
163,938
% of Holdings
3.4%
ARVINAS, INC. (ARVN)
Cacace Angela M — Chief Scientific Officer
Shares
4,592
Price
$11.89
Total Value
$54.60K
Shares Held After
151,232
% of Holdings
2.9%
ARVINAS, INC. (ARVN)
Saik Andrew — Chief Financial Officer
Shares
5,134
Price
$11.89
Total Value
$61.04K
Shares Held After
159,267
% of Holdings
3.1%
ARVINAS, INC. (ARVN)
Teel Randy — Director
Shares
4,403
Price
$11.89
Total Value
$52.35K
Shares Held After
154,482
% of Holdings
2.8%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Shah Gaurav — CEO
Shares
12,279
Price
$3.31
Total Value
$40.67K
Shares Held After
1,052,045
% of Holdings
1.2%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Militello John — Vice President of Finance, Treasurer, Principal Accounting Officer
Shares
3,726
Price
$3.31
Total Value
$12.34K
Shares Held After
92,176
% of Holdings
3.9%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Wilson Martin — General Counsel
Shares
12,253
Price
$3.31
Total Value
$40.58K
Shares Held After
683,376
% of Holdings
1.8%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President & Immunovant CEO
Shares
200,000
Price
$26.49
Total Value
$5.30M
Shares Held After
1,654,597
% of Holdings
10.8%
Avadel Pharmaceuticals plc (AVDL)
Weiss Asset Management LP — Former 10% Owner
Shares
11,112,052
Price
$21.00
Total Value
$233.35M
Shares Held After
0
% of Holdings
100.0%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Cohen Yuval — Director
Shares
13,871
Price
$7.78
Total Value
$107.95K
Shares Held After
174,316
% of Holdings
7.4%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
57,952
Price
$1.31
Total Value
$75.88K
Shares Held After
1,443,641
% of Holdings
4.0%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Moran Sean F. — Chief Financial Officer
Shares
4,701
Price
$7.78
Total Value
$36.59K
Shares Held After
96,694
% of Holdings
4.6%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Tatsis Ourania — EVP, Chief Reg. & Quality Off.
Shares
1,500
Price
$499.99
Total Value
$749.99K
Shares Held After
46,132
% of Holdings
3.1%
Twist Bioscience Corp (TWST)
CHESS ROBERT — Director
Shares
2,184
Price
$48.26
Total Value
$105.40K
Shares Held After
21,084
% of Holdings
9.4%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
291
Price
$63.00
Total Value
$18.33K
Shares Held After
450,335
% of Holdings
0.1%
BRUKER CORP (BRKR)
Munch Mark — EXEC VP&PRES BRUKER NANO INC.
Shares
2,000
Price
$36.94
Total Value
$73.88K
Shares Held After
128,443
% of Holdings
1.5%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bhatia Sangeeta N. — Director
Shares
266
Price
$500.00
Total Value
$133.00K
Shares Held After
4,299
% of Holdings
5.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Biller Jonathan — EVP and Chief Legal Officer
Shares
988
Price
$499.00
Total Value
$493.01K
Shares Held After
16,838
% of Holdings
5.5%
Vir Biotechnology, Inc. (VIR)
Sabatini Brent — SVP, Chief Accounting Officer
Shares
1,530
Price
$7.79
Total Value
$11.92K
Shares Held After
47,872
% of Holdings
3.1%
PULSE BIOSCIENCES, INC. (PLSE)
Danahy Kevin Patrick — Chief Commercial Officer
Shares
20,000
Price
$23.53
Total Value
$470.60K
Shares Held After
43,298
% of Holdings
31.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
1,959
Price
$310.08
Total Value
$607.45K
Shares Held After
23,305
% of Holdings
7.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
2,242
Price
$310.08
Total Value
$695.20K
Shares Held After
59,802
% of Holdings
3.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
1,959
Price
$310.08
Total Value
$607.45K
Shares Held After
31,769
% of Holdings
5.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
6,958
Price
$310.08
Total Value
$2.16M
Shares Held After
85,662
% of Holdings
7.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
2,242
Price
$310.08
Total Value
$695.20K
Shares Held After
24,848
% of Holdings
8.3%
Showing 3451–3500 of 5366 transactions (page 70 of 108)